期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 85, 期 2, 页码 136-138出版社
WILEY
DOI: 10.1038/clpt.2008.245
关键词
-
The advent of molecularly targeted agents has brought major breakthroughs in oncology. However, because these drugs are expensive and financial resources are limited, attention to their cost-effectiveness is rapidly increasing. It seems that establishment of cost-effectiveness is complex but is determined for the most part by the cost of drug acquisition and the drug's efficacy. This article examines the cost-effectiveness of molecularly targeted drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据